腹主动脉瘤合并胃肠道恶性肿瘤:同期与分期手术的系统评价与荟萃分析
该系统评价与荟萃分析纳入1992至2025年间39项研究共641例腹主动脉瘤合并胃肠道恶性肿瘤患者,比较同期与分期手术的围术期及远期结局。
要点
- 同期与分期手术治疗腹主动脉瘤合并胃肠道恶性肿瘤的30天死亡率无显著差异。
- EVAR与开放主动脉修复在结局上无统计学差异。
核心结论
- 同期与分期手术治疗腹主动脉瘤合并胃肠道恶性肿瘤在短期或长期死亡率及疾病相关并发症上无显著差异,但分期手术与更高的30天并发症率相关,提示在选定患者中同期管理可能更安全。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase和Cochrane Central数据库1992至2025年文献,纳入39项研究共641例患者。
- 同期手术组247例,分期手术组394例;同期手术组平均年龄71.8岁(±6.4岁),分期手术组平均年龄72.2岁(±4.2岁)。
主要发现
- 同期手术组中91例(36.8%)先行主动脉修复,其中56例(22.7%)为开放主动脉修复,35例(14.2%)为EVAR。
- 30天死亡率在同期与分期手术之间无显著差异。
- EVAR与开放主动脉修复的结局无统计学差异。
临床怎么用
- 需多学科团队根据动脉瘤相关风险、癌症紧迫性、患者体能及延迟任一治疗的潜在后果进行个体化规划。
- 同期管理在选定患者中可能更安全,尤其采用开放修复时。
局限性
- 纳入研究为回顾性且比较性研究数量有限, findings 应指导个体化多学科规划而非确立所有患者的首选策略。
- 需前瞻性多中心研究以建立该复杂患者群体的明确治疗指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSES: To conduct a systematic review of the literature and perform a meta-analysis to the concurrent occurrence of abdominal aortic aneurysm (AAA) and gastrointestinal (GI) cancer and compare the perioperative and long-term outcomes of simultaneous versus staged treatment strategies. METHODS: A systematic review of the current literature from 1992 to 2025 was performed using PubMed, Embase, and Cochrane Central databases to identify studies reporting surgical treatment of patients with concomitant GI cancer and AAA. RESULTS: Thirty-nine (39) articles including 641 patients were detected. Simultaneous surgery was performed in 247 patients, while staged surgery was performed in 394 patients. The average age of patients undergoing simultaneous surgery was 71.8 years (±6.4 years), while those undergoing staged surgery had an average age of 72.2 years (±4.2 years). In the simultaneous surgery group (SSG), 91 patients (36.8%) underwent AAA repair first, with 56 (22.7%) of them being open aortic repair (OAR) and 35 (14.2%) endovascular aneurysm repair (EVAR). The 30-day mortality showed no significant difference between patients treated in 1 or 2 stages. However, the 30-day complication rate was significantly higher in staged surgeries (STG) compared with SSG with an odds ratio of 0.37 (95% CI, 0.20-0.69, P = .011). Moreover, the outcomes did not differ statistically between the EVAR and OAR methods. CONCLUSIONS: Simultaneous and staged approaches to the treatment of concomitant AAA and GI cancer showed no significant differences in short- or long-term mortality or disease-related complications. However, staged procedures were associated with a higher 30-day complication rate, suggesting that simultaneous management may be safer in selected patients, particularly with the use of open repair. Prospective multicenter studies are needed to establish clear treatment guidance for this complex patient population.Clinical ImpactPatients presenting with both an abdominal aortic aneurysm and gastrointestinal malignancy require coordinated decisions about the timing and sequence of treatment. This systematic review and meta-analysis aims to optimize the management of this complex population and bring together the available evidence comparing simultaneous and staged approaches. Given the retrospective nature and limited number of comparative studies, the findings should inform individualized, multidisciplinary planning rather than establish a preferred strategy for all patients. Clinicians should consider aneurysm-related risk, cancer urgency, patient fitness, and the potential consequences of delaying either treatment.
引用
- El Kanty AE, Kourampi I, Giannopoulos S, et al. Simultaneous Versus Staged Surgery for Concomitant Abdominal Aortic Aneurysm and Gastrointestinal Malignancy: A Systematic Review With Meta-Analysis. J Endovasc Ther. 2026. PMID: 42801481. doi:10.1177/15266028261487352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。